Rigel Pharmaceuticals Inc... (RIGL)
NASDAQ: RIGL
· Real-Time Price · USD
39.55
1.66 (4.38%)
At close: Aug 15, 2025, 3:59 PM
39.51
-0.10%
After-hours: Aug 15, 2025, 07:58 PM EDT
Rigel Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 53.41M | 45.73M | 56.75M | 51.69M | 36.05M | 25.57M | 32.79M | 45.41M | 48.81M | 40.28M | 24.46M | 29.87M | 27.2M | 24.68M | 18.89M | 30.4M | 84.82M | 20.05M |
Short-Term Investments | 54.97M | 31.37M | 20.57M | 9.42M | 13.05M | 23.98M | 24.15M | 16.94M | 15.54M | 18.38M | 33.75M | 51.78M | 61.97M | 82.84M | 106.08M | 112.74M | 68.56M | 19.3M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.18M | 1.52M | 1.44M | 4.76M | 4.74M | 4.32M | 3.06M | 4.96M | 541K | 542K | 640K | 484K | 403K | 464K | 974K | 935K | 840K | 818K |
Receivables | 39.91M | 41.55M | 41.62M | 30.57M | 28.9M | 27.51M | 30.55M | 23.55M | 20.82M | 29.37M | 40.32M | 15.53M | 17.2M | 15.24M | 15.47M | 14.99M | 17.37M | 142.19M |
Inventory | 10.42M | 4.66M | 6M | 4.78M | 10.26M | 7.28M | 5.52M | 6.11M | 10.78M | 11.08M | 9.12M | 7.12M | 6.22M | 6.76M | 6.62M | 7.04M | 6.83M | 6.95M |
Other Current Assets | 5.44M | 6.38M | 10.16M | 9.99M | 6.46M | 8.14M | 6.26M | 3.02M | 4.97M | 7.87M | 8.26M | n/a | n/a | n/a | 7.41M | 5.93M | 6.61M | n/a |
Total Current Assets | 175.39M | 146.56M | 135.1M | 106.47M | 94.72M | 92.49M | 99.27M | 95.02M | 100.92M | 106.97M | 115.9M | 110.44M | 120.52M | 138.94M | 154.47M | 171.1M | 184.2M | 196.76M |
Property-Plant & Equipment | 1.24M | 1.38M | 338K | 504K | 675K | 852K | 1.03M | 1.2M | 1.21M | 1.42M | 2.79M | 4.68M | 7.08M | 9.67M | 11.89M | 14.48M | 16.56M | 18.42M |
Goodwill & Intangibles | 25.92M | 26.51M | 27.1M | 27.69M | 28.27M | 28.86M | 13.88M | 14.15M | 14.41M | 14.68M | 14.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 31.34M | 29.41M | 28.87M | 32.95M | 33.69M | 34.03M | 17.96M | 20.3M | 16.17M | 16.64M | 18.38M | 5.17M | 7.48M | 10.14M | 12.86M | 15.41M | 17.4M | 19.23M |
Total Assets | 206.74M | 175.97M | 163.98M | 139.42M | 128.41M | 126.52M | 117.22M | 115.32M | 117.09M | 123.61M | 134.28M | 115.61M | 128M | 149.07M | 167.33M | 186.52M | 201.6M | 215.99M |
Account Payables | 7.29M | 3.95M | 3.34M | 3.81M | 6.13M | 9.28M | 7.14M | 8M | 5.24M | 6.29M | 22.51M | 2.72M | 2.15M | 4.61M | 3.79M | 3.14M | 1.69M | 5.09M |
Deferred Revenue | 30.86M | 1.35M | 27.8M | 1.35M | 1.35M | 1.35M | 17.04M | 1.35M | 1.35M | 15.46M | 13.51M | 1.37M | 1.54M | 2.1M | 2.6M | 3.16M | 5.81M | 9.5M |
Short-Term Debt | 22.36M | 14.81M | 7.27M | n/a | 639K | 14.78M | 7.92M | 673K | 466K | 449K | n/a | 3.31M | 5.81M | n/a | 9.89M | 9.57M | 9.22M | 8.92M |
Other Current Liabilities | 12.9M | 33.96M | 10.14M | 35.12M | 43.51M | 41.83M | 27.31M | 29.48M | 29.76M | 24.92M | 13.86M | 27.77M | 32.11M | 37.59M | 26.69M | 24.37M | 25.84M | 13M |
Total Current Liabilities | 86.64M | 66.63M | 63.3M | 54.31M | 58.65M | 73.2M | 53.27M | 48.27M | 44.02M | 45.52M | 65.21M | 47.27M | 54.95M | 59.23M | 63.55M | 59.28M | 59.54M | 52.02M |
Long-Term Debt | 37.45M | 44.93M | 52.41M | 59.76M | 59.69M | 44.91M | 52.37M | 59.66M | 59.57M | 59.48M | 39.45M | 39.47M | 29.84M | 83.05M | 19.91M | 3.31M | 5.85M | 8.3M |
Other Long-Term Liabilities | n/a | 44.98M | 44.98M | 39.98M | 39.98M | 39.98M | 39.94M | 38.76M | 40.98M | 42.06M | 42.26M | 48.71M | 46.89M | n/a | 52.73M | 70.94M | 62.24M | 69.08M |
Total Long-Term Liabilities | 38.17M | 90.78M | 97.39M | 99.74M | 99.67M | 84.99M | 92.6M | 98.89M | 101.18M | 102.35M | 82.68M | 88.18M | 76.72M | 83.05M | 73.4M | 77.57M | 73.94M | 85.67M |
Total Liabilities | 124.8M | 157.41M | 160.69M | 154.06M | 158.32M | 158.19M | 145.87M | 147.16M | 145.21M | 147.87M | 147.9M | 135.44M | 131.68M | 142.28M | 136.95M | 136.85M | 133.49M | 137.69M |
Total Debt | 61.04M | 61.07M | 59.97M | 60.23M | 60.33M | 60.5M | 60.58M | 60.8M | 60.67M | 60.73M | 41.55M | 42.78M | 35.65M | 38.14M | 30.57M | 32.77M | 34.94M | 37.06M |
Common Stock | 18K | 18K | 18K | 17K | 17K | 175K | 175K | 175K | 175K | 174K | 174K | 173K | 173K | 172K | 172K | 171K | 171K | 170K |
Retained Earnings | -1.32B | -1.38B | -1.39B | -1.4B | -1.42B | -1.42B | -1.41B | -1.41B | -1.4B | -1.4B | -1.38B | -1.38B | -1.36B | -1.35B | -1.32B | -1.3B | -1.28B | -1.27B |
Comprehensive Income | 6K | -2K | 10K | 11K | -9K | -5K | 8K | -15K | -25K | -27K | -153K | -286K | -438K | -416K | -102K | 8K | 7K | -1K |
Shareholders Equity | 81.93M | 18.57M | 3.29M | -14.64M | -29.91M | -31.67M | -28.64M | -31.83M | -28.11M | -24.26M | -13.62M | -19.83M | -3.68M | 6.8M | 30.37M | 49.67M | 68.11M | 78.3M |
Total Investments | 54.97M | 31.37M | 20.57M | 9.42M | 13.05M | 23.98M | 24.15M | 16.94M | 15.54M | 18.38M | 33.75M | 51.78M | 61.97M | 82.84M | 106.08M | 112.74M | 68.56M | 19.3M |